Stephen Betz
Net worth: 2 M $ as of 2026-05-30
Net worth: 2 M $ as of 2026-05-30
Stephen F.
Betz is the founder of Crinetics Pharmaceuticals, Inc., founded in 2008, where the title held is Chief Scientific Officer since 2021.
Former jobs include Director-Endocrinology & Metabolism at Neurocrine Biosciences, Inc. from 2003 to 2009, and Head-Laboratory Efforts at GeneFormatics, Inc. from 2001 to 2003.
Education history includes an undergraduate degree from the University of Delaware conferred in 1987 and a doctorate from The University of North Carolina at Chapel Hill conferred in 1993.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-19 | 57,451 ( 0.05% ) | 2 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Founder | 2007-12-31 |
| Companies | Position | End |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 2009-04-30 |
GeneFormatics, Inc.
GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Corporate Officer/Principal | 2002-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
GeneFormatics, Inc.
GeneFormatics, Inc. BiotechnologyHealth Technology Provides protein function determination | Health Technology |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crinetics Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions